Literature DB >> 9400824

Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction.

S M Debol1, M J Herron, R D Nelson.   

Abstract

Dapsone has clinical utility as an anti-inflammatory agent but the mechanism of this action remains unknown. We have previously reported that dapsone inhibits beta2 integrin (CD11b/CD18)-mediated adherence of human neutrophils in vitro and now describe studies designed to discover how dapsone-mediated inhibition of this neutrophil function occurs. Results indicate that dapsone interferes with the activation or function of the G-protein (Gi type) that initiates the signal transduction cascade common to chemotactic stimuli. They also show that dapsone-mediated suppression of this pathway inhibits the generation of second messengers essential to the activation of beta2 integrin molecules, as well as respiratory and secretory functions of neutrophils exposed to chemoattractants. We propose that the inhibition of chemoattractant-induced signal transduction by dapsone suppresses neutrophil recruitment and local production of toxic respiratory and secretory products in the affected skin of dermatitis herpetiformis and other neutrophilic dermatoses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400824     DOI: 10.1002/jlb.62.6.827

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

Review 1.  Evaluation of current therapeutic strategies in Behçet's disease.

Authors:  Iliana Alexoudi; Violetta Kapsimali; Aristides Vaiopoulos; Meletios Kanakis; George Vaiopoulos
Journal:  Clin Rheumatol       Date:  2010-09-15       Impact factor: 2.980

Review 2.  Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature.

Authors:  Céline Roman; Bogdan Dima; Laurence Muyshont; Thierry Schurmans; Olivier Gilliaux
Journal:  Eur J Pediatr       Date:  2019-06-22       Impact factor: 3.183

3.  Severe Nodulocystic Acne not Responding to Isotretinoin Therapy Successfully Treated with Oral Dapsone.

Authors:  Lutfi Al-Kathiri; Tasneem Al-Najjar
Journal:  Oman Med J       Date:  2018-09

4.  Treatment of subepidermal immunobullous diseases.

Authors:  Donna A Culton; Luis A Diaz
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

5.  Use of Dapsone in the Treatment of Chronic Idiopathic and Autoimmune Urticaria.

Authors:  Sydney E Liang; Rachel Hoffmann; Erik Peterson; Nicholas A Soter
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

Review 6.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

7.  Microfluidic arenas for war games between neutrophils and microbes.

Authors:  Felix Ellett; Fatemeh Jalali; Anika L Marand; Julianne Jorgensen; Baris R Mutlu; Jarone Lee; Adam B Raff; Daniel Irimia
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

Review 8.  The role of inflammation in the pathology of acne.

Authors:  Emil A Tanghetti
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

9.  Dapsone as an alternative therapy in children with familial mediterranean Fever.

Authors:  Farhad Salehzadeh; Sepideh Jahangiri; Elnaz Mohammadi
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

10.  The management of oral pemphigus vulgaris with systemic corticosteroid and dapsone.

Authors:  Arash Azizi; Shirin Lawaf
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2008-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.